Verve Therapeutics
VERV
#7076
Rank
HK$3.03 B
Marketcap
HK$35.79
Share price
1.10%
Change (1 day)
-59.86%
Change (1 year)

P/S ratio for Verve Therapeutics (VERV)

P/S ratio as of November 2024 (TTM): 18.9

According to Verve Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.7658. At the end of 2024 the company had a P/S ratio of 19.8.

P/S ratio history for Verve Therapeutics from 2021 to 2024

PS ratio at the end of each year

Year P/S ratio Change
202419.8-79.19%
202395.3-84.47%
2022614
2021N/A